ETAMI-Study: Early Thienopyridine Treatment to Improve Primary Percutaneous Coronary Intervention (PCI) in Patients With Acute Myocardial Infarction (ETAMI)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2013 by Stiftung Institut fuer Herzinfarktforschung.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Daiichi Sankyo Inc.
Information provided by (Responsible Party):
Stiftung Institut fuer Herzinfarktforschung
ClinicalTrials.gov Identifier:
NCT01327534
First received: March 29, 2011
Last updated: April 11, 2013
Last verified: April 2013